Like it or not, the term ‘Indo-Pacific’ seems to be a means of including India in the military calculations of US strategy in the Pacific.
The latest plan to get the controversial trade deal up and running again after the withdrawal of the United States involves freezing some of its controversial rules.
Healthcare watchers are calling on India to resist the free trade agreement’s provisions which could compromise India’s ability to keep supplying cheaper generic drugs to the world.
With the RCEP asking for stronger protection for its investors, India is reviewing and trying to replace its investment treaties with a new model.
NAFTA renegotiations may see provisions from the Trans-Pacific Partnership revived, but it must rectify past failings – on income inequality, labour and environmental protection.
Calls for civil resistance against the rise of right-wing populism have emerged. But political activism is more than taking to the streets.
Concerns remain over the impact of RCEP negotiations on public health and access to medicines.
China could take on the US’s attack to try and emerge as a “full fledged super power”.
Trump announced US withdrawal from the TPP because he favours one-on-one agreements with other nations over multilateral pacts.
When it came to race, climate, or diplomacy, Barack Obama was like a visitor from the future. On trade and intervention, however, he was often stuck in the past.
Trump will take opening steps to crack down on immigration, build a wall on the US-Mexican border and roll back Barack Obama’s policies, including Obamacare.
The cabinet of Indian Prime Minister Narendra Modi approved a feasibility study on the proposed deal, clearing the way for the start of formal talks.
With the Regional Comprehensive Economic Partnership agreement, China has an opportunity to be an agenda-setter and demonstrate leadership on global trade.
With the imminent demise of the Tran-Pacific Partnership Agreement almost certain, there are many lessons to be learnt from the fraudulent free trade deal.
Given the likely demise of the TPP, the pressure on India to sign bilateral and regional free-trade deals to counter mega-regional trade pacts has eased.
Park’s office has said she intends to fulfil her duties as president and has not formally acknowledged the calls to step down from the public and parliament.
Trump said he would replace the 12-nation trade accord with bilaterally negotiated deals that would “bring jobs and industry back onto American shores.”
Some European leaders offered uncharacteristically blunt assessments of his fitness to be a party nominee, and their preferred electoral outcome.
The Sinosphere will be no different to Pax Americana and China’s rise should not prompt India to choose sides in a global contest.
Obama will start his talk with Chinese President Xi Jinping tomorrow, but expectations are low as the countries have failed to narrow their main differences.
The trade pact is the economic pillar of Obama’s broader plan to shift US foreign policy toward Asia but the US senate does not plan to vote on the deal this year and will punt it to the next president.
India should not be complacent because of the current uncertainty surrounding TPP. We must fully understand the implications of the various TPP disciplines and how we should strategise ourselves in response to the very many ways they can impact us.
Reductive, reactionary responses to the complex issues of today can be detrimental. Synthesising adequately nuanced solutions is the need of the hour.
Uruguay fights tobacco more strongly than many countries 100 times its size – including the US and it recently won a battle against Philip Morris. Should others follow the example of this tiny nation?
If the current state of bilateral and multilateral economic relations persists, we might end up in a position where India bolsters American strategic primacy with little to show for in return.
The grand bargain that has been struck – India and the US speaking the same language in cyber, climate and intellectual property right regimes, in return for tangible benefits to New Delhi – is not sustainable.
The substantial new barriers against generic entry envisaged by the TPP will not only ensure longer monopoly pricing for pharmaceutical products but also render competition between brand and generic manufacturers unviable
The Trans-Pacific Partnership negotiations were conducted in secrecy and leave out large nations such as China, Brazil and India but it is too early to say if such an arrangement will work
Barack Obama wants to leave behind three big trade liberalising deals as his legacy. He is moving well in that direction. On Monday, as 12 countries — from Canada and Chile to Japan and Australia — reached a deal on the Trans-Pacific Partnership (TPP), which will have huge […]
CBI says it lacks manpower to probe DMAT scam The CBI has expressed its inability to probe a scam linked to Vyapam stating that they lack the manpower to investigate the connected issue. In response to a petition by Anand Rai, the whistleblower behind Vyapam, the CBI said “In […]
If Modi really wants to send a message that India is serious about Korea he must ensure we switch to Korean time for the execution of whatever the two countries agree to do together.